Industry: Corporate Finance
Annual Revenue Estimate: $10bn+
Email Convention: NA
Overall Ranking (88%)
The Overall Ranking is a score from 1 star (very bad) to 5 stars (excellent) generated based on the Company Reviews of current and former employees at this company, taking everything into account.
The number you see in the middle of the donut pie chart is the simple average of these scores. If you hover over the various sections of the donut, you will see the % breakdown of each score given.
The percentile score in the title is calculated across the entire Company Database and uses an adjusted score based on Bayesian Estimates (to account for companies that have few reviews). Simply put, as a company gets more reviews, the confidence of a "true score" increases so it is pulled closer to its simple average and away from the average of the entire dataset.
- 5 Stars
- 4 Stars
- 3 Stars
- 2 Stars
- 1 Star
To gain access to more statistics on this company and thousands of others including:1) % of interns receiving full time offers
2) The top undergraduate schools, majors and degrees this company targets
3) Interview stats breakdown on race, gender, military and sports data on the applicants,
Please click on the lock on the blue arrow and follow the instructions.
Want Access To These Statistics & Rankings?
- Free 1 month access by adding just 1 salary datapoint (here)
- REAL salary bonus data across 1,000+ companies
- Plus free 1 month access to 10,000+ interview insights
AbbVie came from Abbott but hopes to have a life of its own. The pharmaceutical research company was spun off from its former parent, health care products maker Abbott Labs, in early 2013. AbbVie has seven facilities making products that are available in more than 170 countries. Its key drugs include arthritis and Crohn's disease treatment Humira; TriCor, Trilipix, Simcor, and Niaspan for high cholesterol; HIV drugs Kaletra and Norvir; and low testosterone treatment AndroGel, among others. Humira, which is best known as a rheumatoid arthritis drug, accounts for half of AbbVie's sales. With its main product's patent protection expiring in 2016, the R&D company is hard at work looking for the next big thing.
See in Google Maps
1 N. Waukegan Rd., North Chicago, IL, 60064, United States